PURPOSE: To compare clinically 2 different subtypes of Hermansky-Pudlak syndrome (HPS), type 1 (HPS-1) and type 3 (HPS-3). DESIGN: Cross-sectional study of a series of patients. PARTICIPANTS: Sixteen patients with HPS-1 and 14 patients with HPS-3 were studied. METHODS: Complete eye examination, including best-corrected visual acuity and photographs and photographic grading of iris transillumination and macular transparency using a previously established grading system. RESULTS: Snellen visual acuity was 20/160-2 in the HPS-1 group and 20/125+2 in the HPS-3 group (P = 0.017). Iris grading was statistically significant for less translucence in the HPS-3 patients. The HPS-3 patients also tended to have less transparent maculas, but the difference was not statistically significant. CONCLUSIONS: Patients with HPS-3 have less severe ophthalmic manifestations than patients with HPS-1. Ophthalmologists treating patients with albinism should consider HPS in their differential diagnosis even in the case of mild iris and macular hypopigmentation.
PURPOSE: To compare clinically 2 different subtypes of Hermansky-Pudlak syndrome (HPS), type 1 (HPS-1) and type 3 (HPS-3). DESIGN: Cross-sectional study of a series of patients. PARTICIPANTS: Sixteen patients with HPS-1 and 14patients with HPS-3 were studied. METHODS: Complete eye examination, including best-corrected visual acuity and photographs and photographic grading of iris transillumination and macular transparency using a previously established grading system. RESULTS: Snellen visual acuity was 20/160-2 in the HPS-1 group and 20/125+2 in the HPS-3 group (P = 0.017). Iris grading was statistically significant for less translucence in the HPS-3patients. The HPS-3patients also tended to have less transparent maculas, but the difference was not statistically significant. CONCLUSIONS:Patients with HPS-3 have less severe ophthalmic manifestations than patients with HPS-1. Ophthalmologists treating patients with albinism should consider HPS in their differential diagnosis even in the case of mild iris and macular hypopigmentation.
Authors: Yang Zhou; Chuan Hua He; Daniel S Yang; Tung Nguyen; Yueming Cao; Suchitra Kamle; Chang-Min Lee; Bernadette R Gochuico; William A Gahl; Barry S Shea; Chun Geun Lee; Jack A Elias Journal: J Immunol Date: 2018-02-02 Impact factor: 5.422
Authors: Yang Zhou; Chuan Hua He; Erica L Herzog; Xueyan Peng; Chang-Min Lee; Tung H Nguyen; Mridu Gulati; Bernadette R Gochuico; William A Gahl; Martin L Slade; Chun Geun Lee; Jack A Elias Journal: J Clin Invest Date: 2015-06-29 Impact factor: 14.808
Authors: M Huizing; B Pederson; R A Hess; A Griffin; A Helip-Wooley; W Westbroek; H Dorward; K J O'Brien; G Golas; E Tsilou; J G White; W A Gahl Journal: J Med Genet Date: 2009-10-20 Impact factor: 6.318
Authors: Ramin Nazarian; Marjan Huizing; Amanda Helip-Wooley; Marta Starcevic; William A Gahl; Esteban C Dell'Angelica Journal: Mol Genet Metab Date: 2007-10-22 Impact factor: 4.797
Authors: Suh-Young Lee; Chang-Min Lee; Bing Ma; Suchitra Kamle; Jack A Elias; Yang Zhou; Chun Geun Lee Journal: Front Pharmacol Date: 2022-03-17 Impact factor: 5.810